| Literature DB >> 20796285 |
James C Ryan1, Jeanine S Morey, Marie-Yasmine Dechraoui Bottein, John S Ramsdell, Frances M Van Dolah.
Abstract
BACKGROUND: Ciguatoxins (CTXs) are polyether marine neurotoxins and potent activators of voltage-gated sodium channels. This toxin is carried by multiple reef-fish species and human consumption of ciguatoxins can result in an explosive gastrointestinal/neurologic illness. This study characterizes the global transcriptional response in mouse brain to a symptomatic dose of the highly toxic Pacific ciguatoxin P-CTX-1 and additionally compares this data to transcriptional profiles from liver and whole blood examined previously. Adult male C57/BL6 mice were injected with 0.26 ng/g P-CTX-1 while controls received only vehicle. Animals were sacrificed at 1, 4 and 24 hrs and transcriptional profiling was performed on brain RNA with Agilent whole genome microarrays. RT-PCR was used to independently validate gene expression and the web tool DAVID was used to analyze gene ontology (GO) and molecular pathway enrichment of the gene expression data.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20796285 PMCID: PMC2939656 DOI: 10.1186/1471-2202-11-107
Source DB: PubMed Journal: BMC Neurosci ISSN: 1471-2202 Impact factor: 3.288
Figure 1Backbones of Pacific and Caribbean ciguatoxins. A = P-CTX type 1, B = P-CTX type 2, C = C-CTX.
Figure 2Kmeans clustering of medium stringency microarray dataset. 2a-d Pearson metric, 2e-h Euclidean metric. Each color represents the results of a discrete K-means cluster. Each line in the cluster represents the expression of a member gene over the time course. Bar across figures b-d and f-h indicates no change from control animal gene expression.
Comparison of Gene Ontology and metabolic pathway enrichment by cluster metric (Euclidean vs Pearson) for medium stringency dataset.
| Genes | % input | P-Value | Benjam | |
|---|---|---|---|---|
| response to wounding | 28 | 10.6 | 1.7E-15 | 9.2E-12 |
| acute inflammatory response | 17 | 6.4 | 2.6E-15 | 6.9E-12 |
| response to external stimulus | 32 | 12.1 | 5.6E-14 | 9.6E-11 |
| inflammatory response | 20 | 7.6 | 4.3E-11 | 5.6E-08 |
| acute-phase response | 9 | 3.4 | 7.8E-10 | 8.1E-07 |
| response to stress | 31 | 11.7 | 1.0E-07 | 9.0E-05 |
| electron transport | 22 | 8.3 | 2.4E-07 | 1.7E-04 |
| complement activation | 8 | 3 | 9.5E-07 | 6.2E-04 |
| activ of plasma proteins in acute inflam response | 8 | 3 | 9.5E-07 | 6.2E-04 |
| complement activation, classical pathway | 7 | 2.7 | 1.2E-06 | 6.0E-04 |
| wound healing | 10 | 3.8 | 1.8E-06 | 8.5E-04 |
| generation of precursor metabolites and energy | 23 | 8.7 | 2.3E-06 | 1.0E-03 |
| humoral immune response by immunoglobulin | 7 | 2.7 | 3.7E-06 | 1.5E-03 |
| complement activation, alternative pathway | 5 | 1.9 | 4.3E-06 | 1.6E-03 |
| blood coagulation | 8 | 3 | 8.1E-06 | 2.8E-03 |
| coagulation | 8 | 3 | 9.1E-06 | 2.9E-03 |
| defense response | 25 | 9.5 | 9.1E-06 | 2.8E-03 |
| hemostasis | 8 | 3 | 1.1E-05 | 3.2E-03 |
| regulation of body fluid levels | 8 | 3 | 5.0E-05 | 1.4E-02 |
| activation of immune response | 8 | 3 | 7.4E-05 | 1.9E-02 |
| regulation of multicellular organismal process | 14 | 5.3 | 1.1E-04 | 2.7E-02 |
| regulation of immune response | 9 | 3.4 | 1.4E-04 | 3.3E-02 |
| immune response | 19 | 7.2 | 1.5E-04 | 3.4E-02 |
| regulation of immune system process | 9 | 3.4 | 1.6E-04 | 3.3E-02 |
| positive reg of multicellular organismal process | 9 | 3.4 | 2.2E-04 | 4.4E-02 |
| innate immune response | 8 | 3 | 2.2E-04 | 4.4E-02 |
| acute inflammatory response | 8 | 3.8 | 1.5E-05 | 7.5E-02 |
| humoral immune response by immunoglobulin | 6 | 2.8 | 2.1E-05 | 5.3E-02 |
| response to external stimulus | 17 | 8.1 | 2.7E-05 | 4.6E-02 |
| response to wounding | 16 | 24.6 | 3.4E-14 | 1.7E-10 |
| response to external stimulus | 17 | 26.2 | 1.4E-12 | 3.6E-09 |
| acute inflammatory response | 9 | 13.8 | 1.8E-10 | 3.1E-07 |
| acute-phase response | 7 | 10.8 | 2.2E-10 | 2.9E-07 |
| response to stress | 17 | 26.2 | 3.4E-09 | 3.5E-06 |
| wound healing | 8 | 12.3 | 1.6E-08 | 1.4E-05 |
| inflammatory response | 10 | 15.4 | 3.6E-08 | 2.7E-05 |
| blood coagulation | 6 | 9.2 | 1.3E-06 | 8.5E-04 |
| coagulation | 6 | 9.2 | 1.4E-06 | 8.2E-04 |
| hemostasis | 6 | 9.2 | 1.7E-06 | 8.7E-04 |
| regulation of body fluid levels | 6 | 9.2 | 5.2E-06 | 2.4E-03 |
| defense response | 11 | 16.9 | 8.4E-05 | 3.6E-02 |
Genes heading indicates number of genes mapped to an ontology category. % input indicates the percentage of mapped genes from the total number of genes in the cluster. P-Value derived from Fishers exact test and Benjam indicates P-value after application of Benjamini multiple test correction.
Comparison of KEGG molecular pathway enrichment for high, medium and low stringency filtered genes.
| Genes | %input | P-Value | Benjam | |
|---|---|---|---|---|
| Complement and coagulation cascades | 26 | 1.3 | 1.3E-08 | 2.6E-06 |
| Linoleic acid metabolism | 15 | 0.7 | 1.3E-04 | 1.3E-02 |
| Metabolism of xenobiotics by cytochrome P450 | 18 | 0.9 | 5.9E-04 | 3.8E-02 |
| Genes | %input | P-Value | Benjam | |
| Complement and coagulation cascades | 19 | 3.1 | 7.4E-12 | 1.5E-09 |
| Linoleic acid metabolism | 15 | 2.5 | 1.1E-10 | 1.1E-08 |
| Metabolism of xenobiotics by cytochrome P450 | 16 | 2.6 | 5.9E-09 | 3.8E-07 |
| Arachidonic acid metabolism | 10 | 1.7 | 6.2E-04 | 3.0E-02 |
| gamma-Hexachlorocyclohexane degradation | 6 | 1 | 9.1E-04 | 3.5E-02 |
| Genes | %input | P-Value | Benjam | |
| Linoleic acid metabolism | 15 | 2.9 | 1.2E-11 | 2.3E-09 |
| Complement and coagulation cascades | 16 | 3.1 | 7.3E-10 | 7.1E-08 |
| Metabolism of xenobiotics by cytochrome P450 | 15 | 2.9 | 6.0E-09 | 3.9E-07 |
| Arachidonic acid metabolism | 10 | 2 | 1.8E-04 | 8.9E-03 |
| gamma-Hexachlorocyclohexane degradation | 6 | 1.2 | 4.3E-04 | 1.7E-02 |
Genes heading indicates number of genes mapped to an ontology category. % input indicates the percentage of mapped genes from the total number of genes in the cluster. P-Value derived from Fishers exact test and Benjam indicates P-value after application of Benjamini multiple test correction.
Significantly altered genes common to brain, liver and blood.
| Accession # | Sequence Description | 1 hr | 4 hr |
|---|---|---|---|
| NM_019440 | Immunity-related GTPase family M member 2 (Irgm2) | ↑ | |
| NM_029000 | GTPase, very large interferon inducible 1 (Gvin1) | ↓ | |
| AF053745 | Glycosylated gag protein (Mus dunni endogenous virus) | ↑ | |
| NM_007705 | Cold inducible RNA binding protein (Cirbp) | ↑ | |
| NM_008245 | Hematopoietically expressed homeobox (Hhex) | ↓ | |
| NM_026268 | Dual specificity phosphatase 6 (Dusp6) | ↓ | |
| NM_008361 | Interleukin 1 beta (Il1b) | ↓ | |
| NM_010220 | FK506 binding protein 5 (Fkbp5) | ↑ | ↑ |
| BC057864 | Polymeric immunoglobulin receptor 3 precursor (Pigr3) | ↑ | ↑ |
| NM_008330 | Interferon gamma inducible protein | ↓ | |
| NM_007679 | CCAAT/enhancer binding protein (C/EBP), delta | ||
| NM_010907 | NFkB inhibitor, alpha (Nfkbia) | ↑ | ↑ |
| NM_016693 | Mitogen-activated protein kinase kinase kinase 6 (Map3k6) | ↑ | |
| BC021340 | Poly (ADP-ribose) polymerase family, member 14 (Parp 14) | ↓ | |
| NM_007482 | Arginase 1 (Arg1) |
Arrows indicate where gene expression was in the same direction for all three tissues, when at least 2 tissues reported statistically significant data. Blank cells were largely due to the lack of significant data from more than 1 tissue at that particular time point.
Figure 3Validation of microarray results by real-time PCR. Dashed line indicates 1.5 fold change.
Figure 4Complement/Coagulation pathway activation. Adaptation of KEGG Complement and Coagulation pathways. Shaded pathway members were found significant by low stringency filtering of data set while members underlined were found only in the high stringency results.